Back to Podcast
Next Day Prep #339 Neutral

Next Day Prep #339: Healing, Not Healed: Inside a Bearish Breadth Breakout – Friday 10/9/2026

October 9, 2026 6:26
Episode Summary
Despite the regime holding Bearish all day, breadth expanded for a second straight session and broad-based buying pushed the Dow, S&P, and Nasdaq higher together. The team breaks down the SpaceX spectrum deal's tower-stock winners and losers, a multi-catalyst healthcare rebound, and lays out exact levels for SBAC, NET, and TWLO heading into a thin-liquidity Monday ahead of Wednesday's CPI print.
Key Takeaways
  • Broad rally lifted Dow, S&P, Nasdaq despite lagging semiconductors
  • SpaceX spectrum deal sent Crown Castle +15.6%, crushed T-Mobile and AT&T
  • Health care rebounded hard: Humana +11.3%, Moderna +14.2%
  • Breadth improved to 27.2% above 40-day but regime stays Bearish
  • CPI Wednesday and bank earnings are next week's key catalysts
0:00 / 6:26

Today’s Verdict

Situation Awareness: Bearish regime, but the internals are quietly improving. Friday delivered a broad-based advance — Dow +0.83% to 51655, S&P 500 +0.59% to 7811, Nasdaq +0.64% to 27387 — driven almost entirely by company-specific catalysts rather than the AI mega-cap engine, with semiconductors (SOX -0.4%) lagging again. Note: SPY/QQQ/IWM ETF price and SMA data are unavailable today, so I cannot cite specific ETF levels or 200-day positioning. Trade mode for tomorrow: selective and opportunistic — lean into the breadth broadening but respect a sub-30% breadth backdrop. The defining story was SpaceX’s $8B spectrum grab lighting up tower REITs while gutting the wireless carriers, plus a health care rebound and an OpenAI revenue reassurance that steadied the AI trade. Regime context — 27.16% of stocks closed above their 40-day SMA (vs 24.9% prior day, regime held at Bearish), and the 4% Bull/Bear gauge shows 132 bulls vs. 100 bears, a sharp flip from yesterday’s 177/290. The 5-day trend turned up with breadth expanding two sessions running, signaling early, tentative recovery beneath a still-fragile tape.

SIP: CCI DNA CEG TWST

  • What’s working: Continuation/2LYNCH fired 6 signals (IBRX, WAT, ELV, SBAC, TWLO, NET), D9M logged 2 (IBRX, FSLY), Reversal Bullish produced 3 (MCHP, RKLB, PL), and 9M Catalyst flagged CCI — software and medical names dominated the quality signals.
  • Leading sectors (Sector Movers data): Healthcare +1.0%, Industrials +0.19%, Consumer Defensive +0.18%; leading themes: General Industrial Machinery +8.97%, Medical Research Equipment +3.19%, Revenue Biotech +2.0%.
  • Key event: SpaceX’s agreement to acquire Grain Management’s nationwide 800 MHz spectrum sent Crown Castle +15.60% and SBA higher while crushing T-Mobile -13.27% and AT&T -9.85%.
  • Regime threading: morning SA called Bearish (24.9%), closing is Bearish (27.2%) — held because breadth remains below 30%, but the +2.3pp day-over-day improvement is constructive.
  • DEP watchlist (D9M): IBRX at $10.51, FSLY at $29.30 — both momentum names clearing with elevated RVOL.
  • SIPS (Continuation swing candidates): NET $363.39, TWLO $289.36, SBAC $182.34 for tomorrow.

Market Scorecard

  • Index ETFs unavailable: SPY, QQQ, and IWM price/SMA data show as unavailable today — no ETF-specific levels can be cited. Using briefing index data: S&P 500 +0.59% (7811.61), Nasdaq +0.64% (27387.11), Dow +0.83% (51655.16), with the Russell 2000 +0.5% and S&P MidCap 400 +0.5% participating.
  • Breadth: 27.16% of stocks above the 40-day SMA (up from 24.86%), 20% above the 20-day (up from 19%). The 5-day trend is turning up — Bull 4% improved to 132 vs 100 bears, versus yesterday’s deeply negative 177/290 spread.
  • Volume/participation: NYSE advancers led decliners 1528 to 1167 on 1.08 bln shares; Nasdaq 2809 to 2053 on 6.87 bln. Solid participation across nine of eleven sectors suggests accumulation in the broad market even as semis saw distribution.

Today’s Scorecard — What Worked & What Didn’t

  • Winner — Tower REITs & the SpaceX trade: Crown Castle +15.60% ($79.64) led the real estate sector’s +1.9% surge; SBAC +7.3% to $182.34 printed a continuation signal. The 9M Catalyst scan flagged CCI directly.
  • Winner — Health care rebound: Humana +11.34% on regaining four-star Medicare Advantage status, Moderna +14.21% and NVAX +13.84% on cancer-vaccine fast-track reporting; Revenue Biotech theme +2.0%, ELV +2.9% on the continuation scan.
  • What failed — Wireless carriers & semis: T-Mobile -13.27%, AT&T -9.85% cratered the communication services sector (-0.4%, worst on the board); Apple -1.10% and Skyworks -5.45% dragged on the iPhone 18 production-cut report, and the SOX fell another 0.4%. Fabless Semis theme -2.56%.
  • Breadth context: Final reading of 27.16% above the 40-day keeps us technically Bearish, but two consecutive up days in breadth and a positive 4% Bull/Bear flip point to a healing broad market under the surface.

Key Earnings & Economic Calendar

  • Today’s reactions: Delta Air Lines slid ~1.9% after missing Q3 EPS and guiding FY26 to $5.10–5.60 (midpoint below consensus), though its CEO flagged no booking slowdown. American Express fell ~1.8% on a $350M regulatory penalty.
  • Macro miss: University of Michigan Consumer Sentiment (October prelim) dropped to 46.3 vs 48.1 consensus and 48.1 prior — a continued deterioration as cost-of-living frustration builds.
  • Monday (tomorrow): Treasury market closed for Columbus Day; NYSE open for a regular session. No major economic releases scheduled — expect thinner liquidity.
  • Week ahead to prep: Tuesday NFIB Small Business Optimism (98.0 consensus) and Existing Home Sales; Wednesday September CPI (0.6% consensus) / Core CPI (0.2%) plus Beige Book; Thursday PPI (0.5%). Major bank earnings kick off the season, with TSM (TSM $453.28) the key AI-demand read.

Tomorrow’s Watchlist & Setups

  • SBAC at $182.34 — Continuation breakout (+7.3%, RVOL 2.1) riding the SpaceX tower-tenant thesis; institutional-tagged, relatively low ATR (0.5) for a tight-risk entry above today’s high.
  • NET at $363.39 — Software Darvas Box breakout (+6.3%), institutional ownership; watch for a hold above $363 to confirm continuation, ATR%-M 3.4 means size down.
  • TWLO at $289.36 — Continuation setup (+4.9%), institutional; cleaner risk profile (85% risk-ATR) than peers — entry on strength through today’s high.
  • FSLY at $29.30 — D9M momentum name (+15.9%, RVOL 1.8) but sitting at daily supply ($29.46–$32.80, 0.55% away); only chase on a decisive break, otherwise wait for a pullback to the $24–25 demand zone.
  • Sector focus: Health care and biotech — the rebound had multiple independent catalysts (HUM, MRNA, NVAX) and the Revenue Biotech theme (+2.0%) plus IBRX’s D9M signal suggest follow-through potential.

Strategy Outlook & Scenarios

  • Bullish scenario: A third consecutive breadth expansion pushing % above the 40-day through 30% would upgrade the regime toward Cautious; confirmation comes if health care and tower REITs extend and the SOX stabilizes rather than bleeds further.
  • Bearish scenario: A failed OpenAI/AI-revenue narrative or soft TSM read next week re-pressuring semis, combined with breadth rolling back under 24%, would deepen the Bearish regime toward Correction. Hot CPI Wednesday (>0.6%) with the 10-yr pushing back toward 5.36% is the macro trigger.
  • Signal counts: 2LYNCH: 6, D9M: 2, Reversal: 3, plus 35 Darvas Box and 1 9M Catalyst — a modest uptick in constructive setups versus the thin environment, concentrated in software and medical.
  • Tomorrow’s regime forecast: Bearish, drifting toward Cautious. Breadth trajectory is improving but still below 30%, and a bond-market holiday with light volume argues against conviction moves — treat Monday as a positioning/observation day ahead of Wednesday’s CPI.

Action Codes

  • CRT (Controlled Risk Taking): With breadth still sub-30% but improving, take selective swings only in confirmed leaders (SBAC, NET, TWLO) with tight stops — capital preservation first.
  • T3A (Think 3 Days Ahead): Wednesday CPI and the start of bank/TSM earnings loom; position lightly Monday, keep dry powder, and let the data confirm the breadth broadening before committing size.

Summary & Final Thoughts

  • Game plan: Trade Monday selectively and small — favor confirmed breakouts in software, health care, and tower REITs while the bond-market holiday keeps volume thin and the real catalyst (CPI) sits two days out.
  • Key risk: The AI/semiconductor complex remains the market’s fault line — a soft TSM read or renewed OpenAI revenue doubts could unwind the fragile breadth recovery quickly; Apple’s production cut is a warning shot.
  • Overall stance: Selective. The tape is broadening encouragingly beneath a technically Bearish headline, but a 27% breadth reading demands discipline, not aggression — earn the right to add risk as breadth clears 30%.
Share:

Find momentum stocks in milliseconds

Try WaveFinder